Related Experiment Video
Updated: Jun 9, 2026

Integration of Bioinformatics Approaches and Experimental Validations to Understand the Role of Notch Signaling in Ovarian Cancer
Published on: January 12, 2020
Notch signaling in solid tumors
1Ecole Polytechnique Fédérale de Lausanne (EPFL), Swiss Institute for Experimental Cancer Research (ISREC), Lausanne, Switzerland.
Abstract:
In recent years a substantial body of evidence derived from not only preclinical but also clinical studies has accumulated in support of Notch signaling playing important oncogenic roles in several types of cancer. The finding that activating Notch mutations are frequently found in patients suffering from acute lymphoblastic leukemia is one of the best examples for a critical role of Notch signaling in cancer, a fact that motivated many researchers and clinicians to study the role of Notch also in solid tumors. Hence Notch signaling has gained increasing attention as a potential therapeutic target. In this book chapter we would like to discuss our current knowledge of Notch signaling within different types of solid cancers as well as advantages and disadvantages of potential new therapies that try to target the oncogenic properties of Notch signaling.
Insights
Notch signaling is crucial in cancer development, particularly in acute lymphoblastic leukemia. This chapter reviews Notch signaling in solid tumors and evaluates targeted therapies, highlighting their pros and cons.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Research
Background:
- Growing evidence links Notch signaling to oncogenesis in various cancers.
- Activating Notch mutations in acute lymphoblastic leukemia underscore its critical role.
- This has spurred research into Notch signaling's involvement in solid tumors.
Purpose of the Study:
- To review current knowledge of Notch signaling in solid cancers.
- To discuss the advantages and disadvantages of novel Notch-targeted therapies.
Main Methods:
- Review of preclinical and clinical studies.
- Analysis of existing literature on Notch signaling in solid tumors.
- Evaluation of therapeutic strategies targeting Notch.
Main Results:
- Notch signaling plays significant oncogenic roles in diverse solid tumors.
- Targeting Notch signaling presents potential therapeutic benefits.
- Challenges and limitations exist for current and emerging therapies.
Conclusions:
- Notch signaling is a validated therapeutic target in oncology.
- Further research is needed to optimize Notch-targeted treatments for solid cancers.
- Understanding Notch pathway intricacies is key for effective cancer therapy.
Related Concept Videos
Notch Signaling Pathway
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not until 1985...
Notch Signaling Pathway
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not until 1985...
Role Of Notch Signalling In Intestinal Stem Cell Renewal
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
